Is de-escalation of antimicrobials effective? A systematic review and meta-analysis

Int J Infect Dis. 2016 Aug:49:71-9. doi: 10.1016/j.ijid.2016.06.002. Epub 2016 Jun 9.

Abstract

Background: De-escalation therapy is a strategy used widely to treat infections while avoiding the use of broad-spectrum antimicrobials. However, there is a paucity of clinical evidence to demonstrate the effectiveness and safety of de-escalation therapy compared to conventional therapy.

Methods: A systematic review and meta-analysis was conducted on de-escalation therapy for a variety of infections. A search of the MEDLINE (via PubMed), EMBASE, and Cochrane Library databases up to July 2015 for relevant studies was performed. The primary outcome was relevant mortality, such as 30-day mortality and in-hospital mortality. A meta-analysis was to be conducted for the pooled odds ratio using the random-effects model when possible. Both randomized controlled trials and observational studies were included in the analysis.

Results: A total of 23 studies were included in the analysis. There was no difference in mortality for most infections, and some studies favored de-escalation over non-de-escalation for better survival. The quality of most studies included was not high.

Conclusions: This review and analysis suggests that de-escalation therapy is safe and effective for most infections, although higher quality studies are needed in the future.

Keywords: De-escalation therapy; Meta-analysis; Systematic review.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Anti-Infective Agents / therapeutic use*
  • Community-Acquired Infections / drug therapy
  • Cross Infection / drug therapy
  • Hospital Mortality
  • Humans
  • Infections / drug therapy*
  • Intensive Care Units
  • Pneumonia / drug therapy
  • Pneumonia, Ventilator-Associated / drug therapy
  • Sepsis / drug therapy

Substances

  • Anti-Infective Agents